Safety and tolerability of the protein C activator AB002 in end-stage renal disease patients on hemodialysis: a randomized phase 2 trial
Article in Communications Medicine (July 2024)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Article in Communications Medicine (July 2024)
Article in Fluids and Barriers of the CNS (July 2024)
Article in Blood Advances (June 2024)